Section 1 Short title
This Act may be cited as the “Dependent Controlled Substance Transparency Act”.
Dependent Controlled Substance Transparency Act
A BILL
To allow health plan policyholders to obtain information about controlled substances prescribed to adult children enrolled in such plan.
Sec. 2 Privacy exception with respect to controlled substances prescribed to dependents
In general— Notwithstanding the privacy regulations promulgated under section 264(c) of the Health Insurance Portability and Accountability Act of 1996 (Public Law 104–191; 42 U.S.C. 1320d–2 note) or any other provision of law, in the case of an adult child enrolled in a group health plan or in group or individual health insurance coverage as a dependent of the policyholder of such plan or coverage, a covered entity shall make available to such policyholder, upon request, information relating to any controlled substance prescribed to such adult child.
Exception— Subsection (a) shall not apply in the case of a controlled substance prescribed to an adult child as medication-assisted treatment for a substance use disorder.
Definitions— In this section—
the term controlled substance has the meaning given such term in section 102 of the Controlled Substances Act (21 U.S.C. 802);
the term covered entity has the meaning given such term in section 160.103 of title 45, Code of Federal Regulations (or any successor regulations)); and
the terms group health plan and health insurance issuer have the meanings given such terms in section 2791 of the Public Health Service Act (42 U.S.C. 300gg–91).